Effects of omalizumab in a patient with three types of chronic urticaria

British Journal of Dermatology

Volumn 170, Issue 2, 2014, Pages 469-471

  Vieira Dos Santos, R ^a   Locks Bidese, B ^a   Rabello De Souza, J ^a   Maurer, M ^b  

^a Faculdade Evangelica de Medicina do Parana   (Brazil)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTI-ALLERGIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; CHRONIC DISEASE; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; URTICARIA;

EID: 84894268482     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12628     Document Type: Letter

References (8)

1. Zuberbier T, Asero R, Bindslev-Jensen C, et al,. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-26.
2. Zuberbier T, Asero R, Bindslev-Jensen C, et al,. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427-43.
3. Kaplan A, Ledford D, Ashby M, et al,. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol 2013; 132: 101-9.
4. Maurer M, Rosén K, Hsie HJ, et al,. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. New Engl J Med 2013; 368: 924-35.
5. Metz M, Altrichter S, Ardelean E, et al,. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol 2011; 154: 177-80.
6. Magerl M, Borzova E, Giménez-Arnau A, et al,. The definition and diagnostic testing of physical and cholinergic urticarias-EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy 2009; 64: 1715-21.
7. Altrichter S, Peter HJ, Pisarevskaja D, et al,. IgE mediated autoallergy against thyroid peroxidase-a novel pathomechanism of chronic spontaneous urticaria? PLoS ONE 2011; 6: e14794.
8. Maurer M, Altrichter S, Bieber T, et al,. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase. J Allergy Clin Immunol 2011; 128: 202-9.